Fragile X (FMR1) CGG Repeat Analysis Test in Bandra50+ booked in last 3 days
Test determines CGG repeats in the FMR1 gene to diagnose Fragile X syndrome. Test uses TP-PCR/Capillary Electrophoresis. Methylation analysis is used to distinguish between premutation and full mutation alleles.
Summary Price Of Fragile X (FMR1) CGG Repeat Analysis Test in Bandra
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Fragile X (FMR1) CGG Repeat Analysis Test with a clear pricing structure
The price of Fragile X (FMR1) CGG Repeat Analysis Test in Bandra is ₹ 6,900
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
To make an online appointment, get in touch with Metropolis.
Frequently Asked Questions
This test is done to diagnose Fragile X syndrome.
This test is offered to children with development delays, learning disabilities, social & behavioural disorders.
Test determines CGG repeats in the FMR1 gene to diagnose Fragile X syndrome (FXS). Triplet repeat primed PCR (TP-PCR) is used to detect presence or absence of pathogenically expanded allele and hence determines Premutation (Carrier state) and Full mutation (Affected) in the individual.
The FMR1 gene makes a protein called FMRP which is needed for brain development and due to the genetic defect the protein is not produced resulting in development delay, learning, social & behavioural disorders in child.
Ratings & Reviews (0)
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.